Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Serine/threonine-protein kinase Genghis Khan | 0.0189 | 0.259 | 0.26 |
Echinococcus multilocularis | GTPase activating Rap:RanGAP domain 3 | 0.0187 | 0.2552 | 0.3705 |
Loa Loa (eye worm) | STE/STE20/MSN protein kinase | 0.0447 | 0.6889 | 0.6915 |
Schistosoma mansoni | mitogen-activated protein kinase kinase kinase 3 mapkkk3 mekk3 | 0.0187 | 0.2552 | 0.2552 |
Schistosoma mansoni | mitogen-activated protein kinase kinase kinase 3 mapkkk3 mekk3 | 0.0187 | 0.2552 | 0.2552 |
Brugia malayi | hypothetical protein | 0.0187 | 0.2552 | 0.2552 |
Schistosoma mansoni | protein kinase | 0.0447 | 0.6889 | 0.6889 |
Echinococcus granulosus | serine:threonine protein kinase mig 15 | 0.0632 | 0.9962 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.1841 | 0.1848 |
Schistosoma mansoni | protein kinase | 0.0634 | 1 | 1 |
Trypanosoma brucei | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative | 0.0187 | 0.2552 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0187 | 0.2552 | 0.2552 |
Echinococcus multilocularis | 0.0447 | 0.6889 | 1 | |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0189 | 0.259 | 0.376 |
Echinococcus granulosus | GTPase activating Rap:RanGAP domain 3 | 0.0187 | 0.2552 | 0.2562 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0189 | 0.259 | 0.259 |
Loa Loa (eye worm) | hypothetical protein | 0.0187 | 0.2552 | 0.2562 |
Brugia malayi | Protein kinase domain containing protein | 0.0189 | 0.259 | 0.259 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.1841 | 0.1848 |
Onchocerca volvulus | 0.0187 | 0.2552 | 1 | |
Schistosoma mansoni | vam6/vps39 related | 0.0187 | 0.2552 | 0.2552 |
Schistosoma mansoni | rap gtpase-activating protein | 0.0187 | 0.2552 | 0.2552 |
Loa Loa (eye worm) | STE/STE20/KHS protein kinase | 0.0189 | 0.259 | 0.26 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0189 | 0.259 | 0.376 |
Echinococcus granulosus | Vam6:Vps39 protein | 0.0187 | 0.2552 | 0.2562 |
Loa Loa (eye worm) | hypothetical protein | 0.0187 | 0.2552 | 0.2562 |
Brugia malayi | Temporarily assigned gene name protein 59 | 0.0187 | 0.2552 | 0.2552 |
Trypanosoma cruzi | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative | 0.0187 | 0.2552 | 0.5 |
Trypanosoma cruzi | Vacuolar sorting protein 39 domain 1/Vacuolar sorting protein 39 domain 2, putative | 0.0187 | 0.2552 | 0.5 |
Echinococcus granulosus | protein kinase | 0.0447 | 0.6889 | 0.6915 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0189 | 0.259 | 0.259 |
Schistosoma mansoni | protein kinase | 0.0189 | 0.259 | 0.259 |
Loa Loa (eye worm) | hypothetical protein | 0.0187 | 0.2552 | 0.2562 |
Loa Loa (eye worm) | hypothetical protein | 0.0632 | 0.9962 | 1 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.0189 | 0.259 | 0.26 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.1841 | 0.1841 |
Echinococcus multilocularis | serine:threonine protein kinase MRCK beta | 0.0189 | 0.259 | 0.376 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.0189 | 0.259 | 0.26 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (binding) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)] | ChEMBL. | No reference |
Potency (functional) | = 63.0957 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.